Financial Ratios

GLOBAL HEALTH LTD.

NSE : MEDANTABSE : 543654ISIN CODE : INE474Q01031Industry : Hospital & Healthcare ServicesHouse : Private
BSE1323.70-15.85 (-1.18 %)
PREV CLOSE ( ) 1339.55
OPEN PRICE ( ) 1358.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9807
TODAY'S LOW / HIGH ( )1284.70 1358.50
52 WK LOW / HIGH ( )472.6 1513.75
NSE1321.15-19 (-1.42 %)
PREV CLOSE( ) 1340.15
OPEN PRICE ( ) 1352.00
BID PRICE (QTY) 1321.15 (332)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 408690
TODAY'S LOW / HIGH( ) 1285.30 1353.90
52 WK LOW / HIGH ( )472 1513.9
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)9.828.6411.5520.8212.81
   CEPS(Rs)13.0312.085.858.166.25
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)92.6168.49286.13271.92249.48
   Tax Rate(%)25.1526.0432.1521.5234.79
Margin Ratios
   Core EBITDA Margin(%)20.8221.5814.0914.849.97
   EBIT Margin(%)19.5718.629.2611.108.16
   Pre Tax Margin(%)17.9516.766.888.896.70
   PAT Margin (%)13.4312.404.676.984.37
   Cash Profit Margin (%)17.8317.3411.8113.6810.66
Performance Ratios
   ROA(%)7.978.302.595.463.63
   ROE(%)12.4813.884.158.005.38
   ROCE(%)17.2319.517.6911.308.29
   Asset Turnover(x)0.590.670.550.780.83
   Sales/Fixed Asset(x)1.361.280.911.161.22
   Working Capital/Sales(x)1.964.266.568.406.84
Efficiency Ratios
   Fixed Capital/Sales(x)0.740.781.100.870.82
   Receivable days32.2431.3241.3738.7540.02
   Inventory Days7.667.419.516.895.83
   Payable days97.7287.93139.28142.14130.54
Valuation Parameters
   PER(x)53.600.000.000.000.00
   PCE(x)40.390.000.000.000.00
   Price/Book(x)5.680.000.000.000.00
   Yield(%)0.00
   EV/Net Sales(x)6.67-0.15-0.12-0.08-0.02
   EV/Core EBITDA(x)27.83-0.65-0.74-0.43-0.11
   EV/EBIT(x)34.07-0.82-1.31-0.69-0.19
   EV/CE(x)3.48-0.09-0.06-0.06-0.01
   M Cap / Sales7.200.000.000.000.00
Growth Ratio
   Net Sales Growth(%)11.0243.80-16.622.157.29
   Core EBITDA Growth(%)12.93106.61-23.1925.7716.58
   EBIT Growth(%)16.69189.25-30.4938.9427.39
   PAT Growth(%)20.32281.92-44.2563.2768.58
   EPS Growth(%)13.61-25.21-44.5262.5666.39
Financial Stability Ratios
   Total Debt/Equity(x)0.040.070.020.020.11
   Current Ratio(x)3.522.371.701.671.85
   Quick Ratio(x)3.422.241.581.551.75
   Interest Cover(x)12.0510.013.895.025.57
   Total Debt/Mcap(x)0.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.